AstraZeneca PLC cut 600 commercial jobs in the United States late last week as part of a three-year cost-saving initiative.
AstraZeneca cuts 600 US jobs
AstraZeneca has eliminated around 600 jobs in its United States respiratory and immunology commercial teams. The cuts are part of a broader three-year initiative to reduce expenses and reinvest in the company drug pipeline.
Xurve View
Insights:
Xurve View
